Medication for Psychosis: Myths and Truths Demian Rose, MD, PhD UCSF Assistant Professor PREP Medical Director PREP Prevention and Recovery of Early Psychosis.

Slides:



Advertisements
Similar presentations
Mental Health Revolution Pat Bracken RCPsych Oct 28 th 2008.
Advertisements

Mental Health Treatment
Schizophrenia What is schizophrenia?  Most disabling and chronic of all mental illnesses  Psychosis: type of mental illness- cannot distinguish reality.
Preventing the First Episode of Psychosis
New England Journal of Medicine October 18;367: Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease Molly Moncrieff.
Assessment and Differential Diagnosis of Abnormal Experience
SCHIZOPHRENI A. Psychosis – loss of contact with reality SCHIZOPHRENIA IS A TYPE OF PSYCHOSIS.
Diagnosis and Management of Schizophrenia
SUD Module C: Care Management. or……. How to not cure anyone & still accomplish something & go home happy.
Theory to Treatment Schizophrenia Psychopathology Julianne Carroll.
IzBen C. Williams, MD, MPH Instructor. Lecture 10 SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS.
How to Assess for Early Psychosis Rachel Loewy, PhD UCSF Prodrome Assessment Research and Treatment (PART) Program.
University Hospital “Sisters of Charity” Psychiatric Clinic Vinogradska c. 29, 1000 Zagreb, Croatia Davor Moravek Addiction and psychotic.
TWO TOPICS DEFINITION OF MENTAL ILLNESS NATURE OF SCHIZOPHRENIA.
Early-Onset Psychosis EARLY: Early Assessment and Resource Linkage for Youth May 15, 2008.
Describe and Evaluate the Cognitive Treatment for Schizophrenia
Erik Messamore, MD, PhD Psychosis: Origin, Occurrence, Treatment.
Psychotic Disorders of the Brain: Basic and Clinical Neuroscience Better Outcomes Cameron S. Carter MD Department of Psychiatry and Center for Neuroscience.
Describe and Evaluate Biological Treatments for Schizophrenia
5 Minutes for 5 Things What can you tell me about the cognitive explanation of schizophrenia?
Psychosis: Early Identification and Intervention Easter Seals Michigan.
The Changing Role of Medication in Advancing Recovery NYAPRS Conference.
Motivational interviewing for patients with severe mental illness
Assertive Case Management & Feedback as a Clinical Intervention Linda May, PhD, MFT – Case Manager Rachel Loewy, PhD – Clinical Director.
Treatments. Therapy Defined Therapy: techniques to help people deal with psychological problems Focus on changing behavior Connected to theoretical perspectives.
1 Clinical Psychology II - Therapies The Big Picture Anxiety Disorders Cognitive Behaviour Therapies and Phobias Mood Disorders Medication and Therapy.
What is psychosis? D B Double
Predictors of adherence and outcome in schizophrenia Richard Drake, Senior Lecturer in Adult Psychiatry, University of Manchester.
Managing Psychosis (NICE Guidelines 2014)
CBT for psychosis PREP Kate Hardy, Clin.Psych.D Post Doctoral Fellow
Competency of Psychiatry Residents in the Treatment of Severe Mental Illness Before and After a Psychiatric Rehabilitation Community Rotation Melinda Randall.
Next-Generation Strategies for the Therapeutic Management of Schizophrenia Diana O. Perkins, MD, MPH Professor, Department of Psychiatry Medical Director.
Experts in PTSD Oto Gordon Psy 496 January 29, 2015.
Schizophrenia: A neuro-developmental disorder of social and cognitive decline Demian Rose, MD, PhD.
WHAT IS THE EVIDENCE ON EFFECTIVENESS OF ANTIPSYCHOTICS IN PERSONS WITH DEMENTIA? 1.
Anxiety Disorders in Older People George T. Grossberg, MD Samuel W. Fordyce Professor Director, Geriatric Psychiatry Saint Louis University School of Medicine.
Engagement, Adherence, Transition to Community & Course Wrap-Up Demian Rose, MD Rachel Loewy, PhD Linda May, PhD, MFT.
1 Long term anti-psychotic treatment in schizophrenia: 30 years of data and experience Nina R. Schooler, Ph.D. Georgetown University School of Medicine.
1 IRIS Initiative to Reduce the Impact of Schizophrenia DON’T DELAY! IT’S TIME TO REDUCE THE IMPACT OF PSYCHOSIS IN YOUNG PEOPLE……. NOW!
By: Dan Chiarello.  Schizophrenia is a chronic, severe, and disabling brain disorder that has affected people throughout history.  It is a disease that.
Long-term Efficacy Data for Psychiatric Drugs Rationale for Long-Term Treatment Earl Giller, MD, PhD Pfizer Global Research & Development Long-Term Efficacy.
Cognitive behavioral therapy CBT
Copyright © 2011 McGraw-Hill Australia Pty Ltd PPTs t/a Abnormal Psychology: Leading Researcher Perspectives 2e by Rieger et al. Edited by Elizabeth Rieger.
LO: To be able to describe and evaluate the Cognitive Treatment for Schizophrenia.
Psychological Therapies Schizophrenia. Introduction Although the use of drugs is crucial in the treatment of schizophrenia, many people do not experience.
Early Intervention inininin Psychosis. What is psychosis? Research has highlighted that psychotic disorders rarely occur suddenly and that psychotic episodes.
Schizophrenia in Older Adults Zvi D. Gellis, PhDStanley G. McCracken, PhD, LCSW Director, Center for Mental Health & AgingSenior Lecturer Hartford Geriatrics.
Biological Treatments of SZ Drugs – Atypical & Typical Learning Objectives.
PSYCHOTIC DISORDER Mental Health First Aid By Mental Health Commission of Canada, 2010.
Early Psychosis, Recognition, and Intervention Options L. Elliot Hong, MD Professor and Director The First Episode Clinic Maryland Psychiatric Research.
Electroconvulsive Therapy (ECT) In Psychiatry today.
Multidimensional Views of Childhood Psychosis and Multimodal Treatment James B. McCarthy, Ph.D., ABPP Pace University.
Psychological treatment of Schizophrenia
Schizophrenia: an inside view
Schizophrenia in Older Adults
Introduction.
Development and Implementation of a Tobacco Cessation Toolkit
Biological treatment for OCD
“Advances in Psychiatry of Japan”
Expansion of Early Psychosis Care in U.S. Community Settings
Is it a potential indicator to initiate HAART?
First Episode Psychosis: Identification, Intervention, & Recovery Strategies March 19, ICB Spring Conference Itasca, Illinois Workshop C.
Multidimensional Views of Childhood Psychosis and Multimodal Treatment
Consultant Psychiatrist and Research Fellow, IoPPN.
Describe and Evaluate the Cognitive Treatment for Schizophrenia
The Changing Role of Medication
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Describe and Evaluate Biological Treatments for Schizophrenia
Describe and Evaluate Biological Treatments for Schizophrenia
Describe and Evaluate Biological Treatments for Schizophrenia
Presentation transcript:

Medication for Psychosis: Myths and Truths Demian Rose, MD, PhD UCSF Assistant Professor PREP Medical Director PREP Prevention and Recovery of Early Psychosis

“Crazy” “Insane” “Out of touch with reality” “Mad” “Psycho” Language Matters Psychosis

“The opposite of neurosis” “Primary process” “Primitive defense mechanisms” “Something underneath”

Language Matters “The term psychotic has historically received a number of different definitions, none of which has achieved universal acceptance…the term …varies to some degree across… categories.” -DSM-IV TR, pg. 297

Myth: Psychosis is “un-understandable” The “real or not” trap Psychosis is that for which we do not have a “good” explanation Image taken from abc.net.au

If you blindfold people for five days, 77% of them will develop visual hallucinations (2). 1. Tien (1991) Soc Psychiatr Epidemiology 2. Merabet (2004) Journal of Neuro-opthalmalogy Auditory verbal hallucinations occur in 10% to 15% of the population (1). Psychotic-like experience is common… …and easily induced Truth: Psychosis is on a continuum

Myth: Psychosis is a freight train The All-or-none trap Chronic Psychosis is a “cliff”: once you fall over it, there’s no coming back

# Months after treatment entry % Patients Relapse-Free Crow et al. (1986). Brit J. Psychiatry, 148, Truth: Treatment Makes a Difference

With proper medication treatment, about 40% of people with schizophrenia will have 2 or more years without significant symptoms (1) For comparison, about 40-80% of people with bipolar disorder treated with proper medication will have 2 or more years without significant symptoms (2) 1.Kane (2008) J Clin Psychiatry 2.Muzina (2005) Aust NZ J Psychiatry 40% without significant symptoms Truth: Remission is a Realistic Goal

Myth: Psychosis = medication deficiency The “if one med is good, then more are better” trap We need to find the “best combo”

Despite decades of trying, no one has found any combination of antipsychotics that outperforms one antipsychotic alone more meds = more side effects = less adherence A low dose regimen that minimizes side effects is effective One med = better adherence 1.Kane (2008) J Clin Psychiatry 2.Zipursky (2005) Truth: One medication is sufficient

Myth: Psychosis = medication deficiency The “if meds treat it well, then it’s Biological ” trap Psychosis “only responds to meds” Psychosis “can’t respond to psychotherapy”

Truth: Meds are one effective treatment But not the only effective treatment.. Cognitive Behavioral Therapy shows promise as an augmentation for schizophrenia (1) and possibly as a sole treatment for very early or prodromal symptoms (2) 1. Cochrane Review: “CBT for Schizophrenia” ( 2. Bechdolf (2006) Eur Arch Psychiatry and Clin Neurosci 3. McFarlane et al (2002) 4. Fisher et al (2009) Psycho-educational Multi-family Groups involve caregivers and peers and significantly reduce relapse(3) Computerized cognitive training shows promise as a safe treatment for symptoms that do not respond well to medications (4)

In Summary: Psychosis is not “fundamentally different” Psychosis responds well to treatment Medication can be effective at low doses There are many scientific treatments available PREP Prevention and Recovery of Early Psychosis